» Articles » PMID: 33866692

Dietary Influences on the Dahl SS Rat Gut Microbiota and Its Effects on Salt-sensitive Hypertension and Renal Damage

Overview
Specialty Physiology
Date 2021 Apr 18
PMID 33866692
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Our previous studies have demonstrated the importance of dietary factors in the determination of hypertension in Dahl salt-sensitive (SS) rats. Since the gut microbiota has been implicated in chronic diseases like hypertension, we hypothesized that dietary alterations shift the microbiota to mediate the development of salt-sensitive hypertension and renal disease.

Methods: This study utilized SS rats from the Medical College of Wisconsin (SS/MCW) maintained on a purified, casein-based diet (0.4% NaCl AIN-76A, Dyets) and from Charles River Laboratories (SS/CRL) fed a whole grain diet (0.75% NaCl 5L79, LabDiet). Faecal 16S rDNA sequencing was used to phenotype the gut microbiota. Directly examining the contribution of the gut microbiota, SS/CRL rats were administered faecal microbiota transfer (FMT) experiments with either SS/MCW stool or vehicle (Vehl) in conjunction with the HS AIN-76A diet.

Results: SS/MCW rats exhibit renal damage and inflammation when fed high salt (HS, 4.0% NaCl AIN-76A), which is significantly attenuated in SS/CRL. Gut microbiota phenotyping revealed distinct profiles that correlate with disease severity. SS/MCW FMT worsened the SS/CRL response to HS, evidenced by increased albuminuria (67.4 ± 6.9 vs 113.7 ± 25.0 mg/day, Vehl vs FMT, P = .007), systolic arterial pressure (158.6 ± 5.8 vs 177.8 ± 8.9 mmHg, Vehl vs FMT, P = .09) and renal T-cell infiltration (1.9-fold). Amplicon sequence variant (ASV)-based analysis of faecal 16S rDNA sequencing data revealed taxa that significantly shifted with FMT: Erysipelotrichaceae_2, Parabacteroides gordonii, Streptococcus alactolyticus, Bacteroidales_1, Desulfovibrionaceae_2, Ruminococcus albus.

Conclusions: These data demonstrate that dietary modulation of the gut microbiota directly contributes to the development of Dahl SS hypertension and renal injury.

Citing Articles

Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping Review.

Shremo Msdi A, Haghparast A, Garey K, Wang E Nutrients. 2025; 17(5).

PMID: 40077695 PMC: 11901721. DOI: 10.3390/nu17050825.


Oxidative Stress in Kidney Injury and Hypertension.

Arendshorst W, Vendrov A, Kumar N, Ganesh S, Madamanchi N Antioxidants (Basel). 2025; 13(12.

PMID: 39765782 PMC: 11672783. DOI: 10.3390/antiox13121454.


Revisiting sex as a biological variable in hypertension research.

Ryan M, Clemmer J, Mathew R, Faulkner J, Taylor E, Abais-Battad J J Clin Invest. 2024; 134(17).

PMID: 39225093 PMC: 11364402. DOI: 10.1172/JCI180078.


Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis.

Bajaj J, OLeary J, Jakab S, Fagan A, Sikaroodi M, Gillevet P Gut Microbes. 2024; 16(1):2392880.

PMID: 39189586 PMC: 11352695. DOI: 10.1080/19490976.2024.2392880.


A new animal model of cardiorenal syndrome could be established by inducing heart failure through coronary artery ligation in spontaneously hypertensive rats.

Zhou B, Zhao J, Li D Sci Rep. 2024; 14(1):18732.

PMID: 39134654 PMC: 11319483. DOI: 10.1038/s41598-024-69662-3.


References
1.
Abais-Battad J, Lund H, Fehrenbach D, Dasinger J, Mattson D . Rag1-null Dahl SS rats reveal that adaptive immune mechanisms exacerbate high protein-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol. 2018; 315(1):R28-R35. PMC: 6087888. DOI: 10.1152/ajpregu.00201.2017. View

2.
Wilck N, Matus M, Kearney S, Olesen S, Forslund K, Bartolomaeus H . Salt-responsive gut commensal modulates T17 axis and disease. Nature. 2017; 551(7682):585-589. PMC: 6070150. DOI: 10.1038/nature24628. View

3.
Elliott P, Stamler J, Dyer A, Appel L, Dennis B, Kesteloot H . Association between protein intake and blood pressure: the INTERMAP Study. Arch Intern Med. 2006; 166(1):79-87. PMC: 6593153. DOI: 10.1001/archinte.166.1.79. View

4.
Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G . Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017; 5(1):14. PMC: 5286796. DOI: 10.1186/s40168-016-0222-x. View

5.
Hashmat S, Rudemiller N, Lund H, Abais-Battad J, Van Why S, Mattson D . Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats. Am J Physiol Renal Physiol. 2016; 311(3):F555-61. PMC: 5142167. DOI: 10.1152/ajprenal.00594.2015. View